Glucose oxidase generates hydrogen peroxide in a glucose concentration-dependent manner, cleaving the self-immolative moiety of the insulin prodrug to release the insulin analogue, enabling insulin activity only under hyperglycaemia and reducing hypoglycaemia risk. This evidence concerns the gene INS and Hyperglycemia.